Home » World Health News » Health News Roundup: Teva Pharm CEO sees $2.5 billion in revenue for Austedo drug by 2027; US FDA panel backs Pfizer's maternal RSV vaccine for protecting infants and more – Devdiscourse
Health News Roundup: Teva Pharm CEO sees $2.5 billion in revenue for Austedo drug by 2027; US FDA panel backs Pfizer's maternal RSV vaccine for protecting infants and more – Devdiscourse